MedTrace Logo

Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers

NCT04688580 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2022-11-04

No results posted yet for this study

Summary

The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics of various formulations of XW10172 in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

XW10172

Various formulations

Sponsors & Collaborators

  • XWPharma

    lead INDUSTRY

Principal Investigators

  • Daniel M. Canafax, PharmD · XWPharma

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-29
Primary Completion
2021-12-14
Completion
2021-12-14

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04688580 on ClinicalTrials.gov